15 Dec The Biden administration’s plan to use march-in rights to address drug prices would kill future world-changing innovations
Joe Allen
STAT, 12/15/2023...
News
14 Dec Biden Targets the Pharmaceutical Industry
The Dispatch, 12/12/2023...
14 Dec Proposed Framework on March-In Rights Dubbed ‘Unprecedented’ by U.S. Chamber
Eileen McDermott
IPWatchdog, 12/7/2023...
14 Dec Biden proposal on ‘march-in’ rights would have limited effect on current drug costs, critics say
Nicole DeFeudis
Endpoints News, 12/7/2023...
14 Dec US sets policy to seize patents of government-funded drugs if price deemed too high
Patrick Wingrove
Reuters, 12/7/2023...
14 Dec Biden administration asserts power to seize drug patents in move to slash high prices
Bertha Coombs
CNBC, 12/7/2023...
14 Dec Biden Administration Says It Plans To Use March-In-Rights For Drugs To Lower Prices
Joshua Cohen
Forbes, 12/7/2023...
11 Dec Domestic manufacturing can be strengthened without sacrificing technological primacy
Jon Soderstrom
Hartford Courant, 12/10/2023...
10 Dec New March-In Guidelines Threaten U.S. Innovation
Joe Allen
IPWatchdog, 12/10/2023...
07 Dec Bayh-Dole Coalition Statement on Biden Administration’s Proposed March-in Framework
WASHINGTON, D.C. (December 7, 2023) -- Today, the Biden administration's Interagency Working Group for Bayh-Dole concluded its review of the federal government's march-in authority under the 1980 Bayh-Dole Act....